Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia

Conditions:   Hydatidiform Mole;   Low Risk Metastatic Gestational Trophoblastic Tumor;   Nonmetastatic Gestational Trophoblastic Tumor;   Uterine ChoriocarcinomaInterventions:   Biological: dactinomycin;   Drug: methotrexateSponsors:   Gynecologic Oncology Group;   National Cancer Institute (NCI);   Eastern Cooperative Oncology GroupCompleted - verified February 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials